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Abstract: A patient presented with acute-onset, postoperative endophthalmitis and visual 
acuity of light perception. Because of a time delay in arranging a pars plana vitrectomy (PPV), 
the patient was treated with a prompt vitreous tap for culture an injection of vancomycin and 
ceftazidime. Four hours later, the PPV was performed and additional antibiotics were injected. 
The cultures from both the initial needle tap and the subsequent PPV isolated methicillin-
  resistant Staphylococcus epidermidis sensitive to vancomycin, but resistant to fourth-generation 
fluoroquinolones. The patient eventually recovered a visual acuity of 20/80 before developing 
retinal detachment. This case illustrates the time lag necessary to sterilize the vitreous cavity, 
and suggests a possible two-step staged treatment strategy for situations in which access to PPV 
equipment and support staff may be limited.
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Introduction
Acute-onset, postoperative endophthalmitis is an uncommon but potentially severe 
complication of cataract surgery.1 Successful treatment of endophthalmitis requires 
accurate microbiologic diagnosis and prompt treatment with effective antimicrobial 
agents.2 The Endophthalmitis Vitrectomy Study (EVS) reported that, for patients 
with acute-onset, postoperative endophthalmitis and presenting visual acuity of light 
perception (LP), initial treatment with pars plana vitrectomy (PPV) and intravitreal 
antibiotics was associated with more favorable visual outcomes than was treatment 
with vitreous tap and intravitreal antibiotics.3 In the EVS, PPV was performed within 
six hours of the initial examination,3 but this may not always be feasible in clinical 
practice. One alternative approach is to perform prompt vitreous tap and injection of 
intravitreal antibiotics, followed by PPV as soon as practicable. We present a case 
of acute-onset, postoperative endophthalmitis managed in this fashion.
Case report
An 86-year-old male presented five days after uncomplicated phacoemulsification and 
posterior chamber intraocular lens implantation, with a 24-hour history of progressive 
visual loss and redness in the operated (left) eye. Past medical history was signifi-
cant for hypertension, dyslipidemia, sleep apnea, and essential tremor. Medications 
included lisinopril, atorvastatin, amlodipine, and propanolol. There were no known drug 
  allergies. On examination, visual acuity was LP. Slit-lamp examination demonstrated Clinical Ophthalmology 2010:5 102
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conjunctival injection, corneal edema, and hypopyon 
  (Figure 1). Dilated fundus examination showed dense vitre-
ous opacification. B-scan echography demonstrated vitreous 
opacification, but no retinal detachment (Figure 2).
The patient had presented to a satellite clinic in a suburban 
location. Access to an operating room with PPV equipment 
and appropriate support staff would not be possible for at 
least several hours. After a full discussion with the patient, 
it was decided to perform prompt vitreous tap and injection 
of intravitreal antibiotics in an attempt to stabilize the eye, 
followed by PPV as soon as the operating room, vitrectomy 
equipment, and the appropriate surgical team could be 
secured. Aqueous and vitreous cultures were obtained by 
needle tap, and the eye was treated with intravitreal injection 
of vancomycin 1 mg/0.1 mL and ceftazidime 2.25 mg/0.1 mL. 
Systemic antibiotics were not administered.
Approximately four hours after the vitreous tap and 
invitreal injection of antibiotics, an operating room became 
available and a 23-gauge PPV was performed. Using the 
vitreous cutter, undiluted vitreous was obtained prior to 
initiating infusion of balanced salt solution. Intraoperative 
findings included dense vitreous opacification and a superior 
retinal break located posteriorly near the equator, which was 
treated with endolaser photocoagulation. There did not appear 
to be a posterior vitreous detachment (PVD) at the time of 
surgery, and no attempt was made to induce a PVD surgically. 
Vancomycin 1 mg/0.1 mL and ceftazidime 2.25 mg/0.1 mL 
were re-injected into the vitreous cavity at the conclusion of 
Figure 1 Slit lamp photograph, left eye, demonstrated layered hypopyon and fibrin formation in the anterior chamber.
Figure 2 B-scan echography, left eye, demonstrated vitreous opacities but no retinal 
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surgery. Fluid-air exchange was not performed. Postopera-
tively, the patient was treated with topical moxifloxacin and 
prednisolone acetate 1%. Again, systemic antibiotics were 
not administered.
The vitreous cultures from both the initial needle tap and 
the subsequent PPV isolated methicillin-resistant Staphy-
lococcus epidermidis sensitive to vancomycin. The patient 
demonstrated clinical improvement and one month later, 
visual acuity improved to 20/80. Unfortunately, the patient 
subsequently developed retinal detachment. A repeat PPV 
was performed, at which time epiretinal membranes, but no 
additional breaks, were identified. The patient was treated 
with PPV, membrane peeling, inferior retinectomy, and 
placement of silicone oil. At three months following presenta-
tion, visual acuity was 20/200 with silicone oil tamponade.
Discussion
In the EVS, 70% of microbiological isolates contained 
coagulase-negative micrococci.3 In this case, persistent 
coagulase-negative staphylococci were isolated from the 
PPV culture four hours following treatment with vancomycin 
and ceftazidime. Antibiotic kill rates are affected by drug 
concentration as well as contact time with the microorgan-
isms. Vancomycin inhibits bacterial cell wall synthesis by 
interfering with peptidoglycan synthesis. Vancomycin is 
initially bacteriostatic and then becomes bactericidal after 
about eight hours.4 The serum killing curves of vancomycin 
against S. aureus demonstrate a lag phase prior to a rapid 
killing phase. This case demonstrates that sterilization of the 
vitreous cavity is by no means immediate. A single intra-
vitreal injection may not sterilize the vitreous cavity even 
after several days. In the EVS, of the 420 patients enrolled, 
33 (8%) were re-cultured within the first week because of 
clinical signs of worsening infection or inflammation, and 
of these 33 patients, 14 (42%) were persistently culture-
positive. Persistent positive cultures were more common in 
patients randomized to initial needle tap (71%) than those 
randomized to initial PPV (13%), and this difference was 
statistically significant (P = 0.001).5
Although the EVS reported an association between PPV 
and more favorable visual outcomes, PPV is usually per-
formed in an operating room with specialized equipment and 
support staff. In some circumstances, it may not be feasible 
to perform PPV within a sufficiently timely fashion, and a 
staged two-step treatment potentially offers the benefits of 
faster initiation of antimicrobial therapy. In the EVS, among 
the subset of patients with LP vision treated with PPV, 11% 
achieved visual acuity of 20/40 or better, 30% achieved visual 
acuity of 20/100 or better, and 47% developed severe visual 
loss, defined as visual acuity of worse than 5/200. There-
fore, this patient, treated with a staged two-step treatment, 
achieved a visual outcome consistent with that reported in 
the EVS.
This patient was not treated with systemic antibiotics. 
The EVS reported no significant difference in outcomes with 
or without the use of systemic amikacin and ceftazidime.3 
Newer fourth-generation fluoroquinolones, such as gati-
floxacin6 and moxifloxacin,7 achieve potentially therapeutic 
intraocular drug levels in the noninflamed eye. Although their 
benefit in the clinical management of acute-onset, postop-
erative endophthalmitis remains unproven, systemic fluoro-
quinolones may be considered in cases similar to this one. 
Systemic gatifloxacin is no longer commercially available in 
the United States due to associated risks of hyperglycemia 
and hypoglycemia.8
During the initial PPV, a superior retinal break was 
identified. This break may have been caused by the endo-
phthalmitis, by the initial vitreous tap and inject, or by the 
PPV. The eye initially improved to a visual acuity of 20/80 
but then developed retinal detachment, which required fur-
ther surgery. It is possible that the staged two-step treatment 
may have increased the risk of retinal detachment, although 
it is also possible that a staged two-step treatment may have 
improved the final outcome.
In the setting of acute-onset, postoperative endophthal-
mitis with visual acuity of LP and no prompt access to an 
operating room, a staged two-step treatment (tap and inject 
followed by PPV) may be a reasonable treatment option. It is 
obviously very difficult to draw definitive conclusions from 
single cases, and further clinical experience is necessary to 
validate this report.
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